[HTML][HTML] Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review

CDM van Karnebeek, S Stockler - Molecular genetics and metabolism, 2012 - Elsevier
BACKGROUND: Intellectual disability ('developmental delay'at age< 5years) affects 2.5% of
population worldwide. Recommendations to investigate genetic causes of intellectual …

Hematopoietic stem cell transplantation in inborn errors of metabolism

EY Tan, JJ Boelens, SA Jones, RF Wynn - Frontiers in pediatrics, 2019 - frontiersin.org
Hematopoietic stem cell transplantation (HSCT) has been established as an effective
therapy for selected inborn errors of metabolism. The success of HSCT in metabolic disease …

Alpha-mannosidosis

D Malm, Ø Nilssen - Orphanet Journal of Rare Diseases, 2008 - Springer
Alpha-mannosidosis is an inherited lysosomal storage disorder characterized by immune
deficiency, facial and skeletal abnormalities, hearing impairment, and intellectual disability. It …

Alpha-mannosidosis: therapeutic strategies

MR Ceccarini, M Codini, C Conte, F Patria… - International Journal of …, 2018 - mdpi.com
Alpha-mannosidosis (α-mannosidosis) is a rare lysosomal storage disorder with an
autosomal recessive inheritance caused by mutations in the gene encoding for the …

Current strategies for the treatment of inborn errors of metabolism

MJ Gambello, H Li - Journal of Genetics and Genomics, 2018 - Elsevier
Inborn errors of metabolism (IEMs) are a large group of inherited disorders characterized by
disruption of metabolic pathways due to deficient enzymes, cofactors, or transporters. The …

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III …

L Borgwardt, N Guffon, Y Amraoui, CI Dali… - Journal of Inherited …, 2018 - Springer
Introduction This phase III, double-blind, randomised, placebo-controlled trial (and extension
phase) was designed to assess the efficacy and safety of velmanase alfa (VA) in alpha …

Enzyme replacement therapy for genetic disorders associated with enzyme deficiency

M Marchetti, S Faggiano… - Current Medicinal …, 2022 - ingentaconnect.com
Mutations in human genes might lead to the loss of functional proteins, causing diseases.
Among these genetic disorders, a large class is associated with the deficiency in metabolic …

Gene therapy for lysosomal storage disorders: a good start

A Biffi - Human molecular genetics, 2016 - academic.oup.com
Lysosomal storage disorders (LSDs) are a heterogeneous group of inherited diseases with
a collective frequency of∼ 1 in 7000 births, resulting from the deficiency in one or more …

Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature

JB Hennermann, EM Raebel, F Donà… - Orphanet journal of rare …, 2022 - Springer
Background Alpha-mannosidosis is a rare autosomal recessive lysosomal storage disorder
(LSD) caused by reduced activity of alpha-mannosidase. Clinical manifestations include …

[HTML][HTML] Hematopoietic stem cell gene therapy to halt neurodegeneration

A Biffi - Neurotherapeutics, 2024 - Elsevier
Microglia play fundamental roles in multiple pathological primary and secondary processes
affecting the central nervous system that ultimately result in neurodegeneration and for this …